Back to Search Start Over

Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program.

Authors :
Jafari, Mehraneh D
Jafari, Mehraneh D
Halabi, Wissam J
Stamos, Michael J
Nguyen, Vinh Q
Carmichael, Joseph C
Mills, Steven D
Pigazzi, Alessio
Jafari, Mehraneh D
Jafari, Mehraneh D
Halabi, Wissam J
Stamos, Michael J
Nguyen, Vinh Q
Carmichael, Joseph C
Mills, Steven D
Pigazzi, Alessio
Source :
JAMA surgery; vol 149, iss 2, 170-175; 2168-6254
Publication Year :
2014

Abstract

ImportanceHyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have been shown to benefit selected patients with peritoneal carcinomatosis. However, these procedures are associated with high morbidity and mortality. Available data investigating the outcomes of HIPEC are mostly limited to single-center studies. To date, there have been few large-scale studies investigating the postoperative outcomes of HIPEC.ObjectiveTo determine the associated 30-day morbidity and mortality of cytoreductive surgery-HIPEC in the treatment of metastatic and primary peritoneal cancer in American College of Surgeons National Surgical Quality Improvement Program centers.Design, setting, and participantsA retrospective review of HIPEC cases performed for primary and metastatic peritoneal cancer diagnoses was conducted. The cytoreductive surgical procedures were sampled, and disease processes were identified. Patient demographics, intraoperative occurrences, and postoperative complications were reviewed from the American College of Surgeons National Surgical Quality Improvement Program from 2005-2011.Main outcomes and measuresThirty-day mortality and morbidity.ResultsOf the cancers identified among the 694 sampled cases, 14% of patients had appendiceal cancer, 11% had primary peritoneal cancer, and 8% had colorectal cancer. The American Society of Anesthesiologists classification was 3 for 70% of patients. The average operative time was 7.6 hours, with 15% of patients requiring intraoperative transfusions. Postoperative bleeding (17%), septic shock (16%), pulmonary complications (15%), and organ-space infections (9%) were the most prevalent postoperative complications. The average length of stay was 13 days, with a 30-day readmission rate of 11%. The rate of reoperation was 10%, with an overall mortality rate of 2%.Conclusions and relevanceAmerican College of Surgeons National Surgical Quality Improvement Program hospitals performing HIPEC have acceptable rates of mo

Details

Database :
OAIster
Journal :
JAMA surgery; vol 149, iss 2, 170-175; 2168-6254
Notes :
application/pdf, JAMA surgery vol 149, iss 2, 170-175 2168-6254
Publication Type :
Electronic Resource
Accession number :
edsoai.on1367464311
Document Type :
Electronic Resource